This Global technology and consulting provider builds on extensive experience supporting the Food and Drug Administration with the award of a new 3-year task to conduct surveillance activities for the safety and effectiveness of biologics.
The post FDA awards $17M Surveillance Activities for Safety and Effectiveness of Biologics task appeared first on G2Xchange Health, a service of MileMarker10.
